The crowds, as it seemed, waited with bated breath for Shashi Tharoor to hit the lectern.
Being billed as the largest bond issued from a local authority, Amaravati Bond 2018, is meant to fund the building of the new state capital for Andhra Pradesh. The bond was listed on the Bombay Stock Exchange (BSE) on Monday.
Those within the pharma industry see a couple of messages coming across from the movie.
Geeks apparently believe that a state government has hardly any influence on their sector and it was partly clear from their poor turnout at the polling stations.
The recent announcement in Mumbai about establishing Krea University in Andhra Pradesh has greater significance than just another liberal arts and sciences institution coming up in India.
The agitation, as is apparent, has moved from the Parliament to national highways and some of the industry leaders Business Today spoke to felt it may be time to brace up for temporary disruptions considering that there are less than 12 months left for the elections. Special Category status after all is also an emotive issue.
Conversations with those within the private aerospace and defence sector in India suggest that it is still early. While some joint ventures have been formed and work has started, manufacturing, especially on a large-scale, is some distance away.
Once known for the books it sold, the e-commerce behemoth has today permeated most lives with products to meet everyday needs - from grocery to gadgets, movies to now even medicines.
Medical professionals rang in the New Year debating the implications of the National Medical Commission Bill tabled in the Lok Sabha. That it has now been sent to the standing committee should hopefully put some concerns to rest considering the bill.
One could argue that a medical regulator need not be dominated by doctors and may need representatives of the civil society, government and others, which is what the National Medical Commission bill seeks.
On Friday, the National Pharmaceutical Pricing Authority without either pronouncing Fortis guilty or absolving it of any wrong doing, just confined itself to saying: "NPPA shall be taking necessary follow up action as per existing law and within its jurisdiction."
Every business has the right to adopt legitimate practises to protect their own interest. Right? But a recent article argues that going beyond the patent act, which permits research and development during the life of a patent, some innovator drug companies are busy trying to block this.
On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price controls.
On August 15th , Shoba, a resident of Medak district near Hyderabad, reached out to Niloufer government hospital for mother and child health, with a newborn suffering from severe jaundice.
On August 3rd, the largest generic company operating in the US, Teva Pharmaceutical Industries (Teva in quickspeak) put out results that arguably jolted the world of global generic medicines.
But then, there are few questions that need to be addressed to ensure the move leads to maximum benefit for the patients.
High profile investment melas by Indian states, backed by big numbers to showcase potential investor interest, are par-for-the-course today.
The passing away of Tamil Nadu chief minister J Jayalalithaa is a major development for industry operating in Tamil Nadu and those considering new investments into the state.
Although there are norms and punishments for overcharging for medicines, but it is not a good idea for a consumer to just depend on the pharmaceutical companies or the pharmacies to get the correct price prescribed by the government as effective monitoring system is absent.
However, there are worries too - a spike in bacterial and microbial infections due to rains. We are into the season of monsoon-related infections that goes on till early winter. It is best to stay away from mosquitoes and contaminated water.
In a hyper-competitive globalised free market era, proponents of an interventionist government would have rejoiced hearing V.K. Saraswat, the accomplished scientist, researcher and member of the Niti Aayog, at a recent meeting of mathematicians and statisticians in Hyderabad.





